However, the current research results are only preliminary, so it is necessary to use inhibitors of the MAPK signaling pathway and TNF-α, as well as knockout mouse models of the MAPK signaling pathway and TNF—α genes, in order to further verify the role of RPR in the MAPK signaling pathway and key targets such as TNF—α in stroke mice. This evidence concerns the gene EXTL3 and stroke disorder.